Tumor Mutational Burden Predicts Progression-Free Survival and Local-Regional Control in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Durvalumab

被引：0
|
作者：
Shaverdian, N. [1 ]
Shepherd, A. F. [1 ]
Offin, M. [2 ]
Gelblum, D. [1 ]
Wu, A. J. [1 ]
Simone, C. B., II [3 ]
Schoenfeld, A. J. [2 ]
Jones, D. [4 ]
Rimner, A. [1 ]
Chaft, J. [4 ]
Riaz, N. [1 ]
Gomez, D. R. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] New York Proton Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2873
引用
收藏
页码：E390 / E391
页数：2
相关论文
共 50 条
  • [31] Pretreatment financial toxicity predicts progression-free survival following concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer
    Klein, Jonathan
    Bodner, William
    Garg, Madhur
    Kalnicki, Shalom
    Ohri, Nitin
    FUTURE ONCOLOGY, 2019, 15 (15) : 1697 - 1705
  • [32] Prognostic Nutritional Index (PNI) predicts progression free survival in patients with unresectable stage III non-small cell lung cancer treated with consolidation durvalumab
    Nindra, Udit
    Shahnam, Adel
    Stevens, Samuel X.
    Pal, Abhijit
    Yip, Po Yee
    Adam, Tamiem
    Lee, Jenny
    Boyer, Michael
    Kao, Steven
    Nagrial, Adnan
    Bray, Victoria J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 166 - 166
  • [33] Acute esophagitis for patients with local-regional advanced non small cell lung cancer treated with concurrent chemoradiotherapy
    Pan, Yi
    Brink, Carsten
    Knap, Marianne
    Khalil, Azza A.
    Nyhus, Christa H.
    McCulloch, Tine
    Holm, Bente
    Wu, Yi-long
    Schytte, Tine
    Hansen, Olfred
    RADIOTHERAPY AND ONCOLOGY, 2016, 118 (03) : 465 - 470
  • [34] Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer
    Zhang, Nasha
    Liang, Rachel
    Gensheimer, Michael F.
    Guo, Meiying
    Zhu, Hui
    Yu, Jinming
    Diehn, Maximilian
    Loo, Bill W., Jr.
    Li, Ruijiang
    Wu, Jia
    THERANOSTICS, 2020, 10 (25): : 11707 - 11718
  • [35] Timing of Salvage Tyrosine Kinase Inhibitors for Patients with Progressive Locally Advanced Non-Small Cell Lung Cancer Initially Treated with Chemoradiation and Consolidative Durvalumab
    Liu, Yufei
    Rinsurongkawong, Waree
    Gay, Carl
    Lewis, Jeff
    Rinsurongkawong, Vadeerat
    Lee, Jack
    Lee, Percy
    Zhang, Jianjun
    Gibbons, Don
    Vaporciyan, Ara
    Heymach, John
    Lin, Steven
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S15 - S16
  • [36] Progression-free survival and one-year milestone survival as surrogates for overall survival in previously treated advanced non-small cell lung cancer
    Zhao, Shen
    Zhang, Zhonghan
    Zhang, Yaxiong
    Hong, Shaodong
    Zhou, Ting
    Yang, Yunpeng
    Fang, Wenfeng
    Zhao, Hongyun
    Zhang, Li
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (11) : 2854 - 2866
  • [37] Number of ALK-amplified circulating tumor cells predicts progression-free survival in ALK-rearranged non-small cell lung cancer patients treated by crizotinib
    Pailler, Emma
    Oulhen, Marianne
    Ross, Kirsty
    Billiot, Fanny
    Auger, Nathalie
    Borger, Isabelle
    NgoCamus, Maud
    Remon-Masip, Jordi
    Planchard, David
    Soria, Jean-Charles
    Besse, Benjamin
    Farace, Francoise
    CANCER RESEARCH, 2016, 76
  • [38] Increasing Pretreatment Tumor SUVmean Is Associated With Local Regional Failure After Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
    Rajpara, R. S.
    Wang, X.
    Chen, Z.
    Schreibmann, E.
    Fox, T.
    Stapleford, L. J.
    Beitler, J. J.
    Curran, W. J.
    Higgins, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S525 - S526
  • [39] Meta-analysis of progression-free survival as a predictor of overall survival in locally advanced or metastatic non-small cell lung cancer trials.
    Turner, Evadne Jane
    McCloud, Philip
    Germanos, Peter
    Dehle, Francis
    Norris, Sarah
    Tan, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy
    Bhatt, P.
    Bonomi, P.
    Basu, S.
    Batus, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S868 - S869
12345